So far, antibodies against thrombin, PC, plasmin, and FXa have been detected in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), allowing researchers to characterize their role in the underlying pathways that lead to disease onset [15]. This evidence concerns the gene PLG and autoimmune polyendocrinopathy.